Innate Pharma SA
F:IDDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Innate Pharma SA
F:IDDA
|
FR |
|
Pyridam Farma Tbk PT
IDX:PYFA
|
ID |
|
Scancell Holdings PLC
LSE:SCLP
|
UK |
|
S
|
Sportech PLC
F:ROEA
|
UK |
|
RemeGen Co Ltd
SSE:688331
|
CN |
|
Amex Exploration Inc
XTSX:AMX
|
CA |
|
Lazydays Holdings Inc
NASDAQ:GORV
|
US |
|
C
|
Compagnie de Saint Gobain SA
F:GOB
|
FR |
|
Groupe Guillin SA
PAR:ALGIL
|
FR |
|
A
|
After You Public Co Ltd
SET:AU
|
TH |
|
Birks Group Inc
F:2BG
|
CA |
|
K
|
Karmarts PCL
SET:KAMART
|
TH |
|
U
|
Union Pioneer PCL
SET:UPF
|
TH |
|
A
|
Asefa PCL
SET:ASEFA
|
TH |
|
P
|
PayPal Holdings Inc
F:2PP
|
US |
|
N
|
Nforce Secure PCL
SET:SECURE
|
TH |
Bankruptcy Probability
Innate Pharma SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Innate Pharma SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Innate Pharma SA
PAR:IPH
|
176m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
467.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
240.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
182.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
55B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Innate Pharma SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Innate Pharma SA has total debt of 13.8m EUR. This includes both short-term (0 EUR) and long-term (13.8m EUR) debt.
You can find a full breakdown on its Balance Sheet.
